Delivery Order SPE2DB25D3021-SPE2DB25FQXDB

Award Date 12/26/24
Potential Completion Date 12/27/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3021
    Indefinite Delivery Contract
  • SPE2DB25D3021-SPE2DB25FQXDB
    Delivery Order

This federal contract award, valued at $4,823.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific award is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. This contract award demonstrates AmerisourceBergen's significant role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to various federal agencies and healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 3/27/25, 9:49 AM